Abstract
Evaluation of breast symptoms and complaints may be appropriately managed by obstetrician-gynecologists in the ambulatory setting. Furthermore, surveillance for signs of breast cancer by mammography and physical examination is the responsibility of the primary health care physician for women, usually the ob/gyn. Diagnosed breast cancer and other breast problems beyond the expertise of the primary care physician should be suitably referred but must be continuously followed to be certain proper treatment is given and the clinical problem is resolved satisfactorily. In most cases, the patient will return to her primary care physician on whom she may rely for lifelong follow-up after her treatment is completed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
ACOG Committee Opinion, Committee on Gynecologic Practice, No. 186, September 1997. Role of the Obstetrician-Gynecologist in the Diagnosis and Treatment of Breast Disease. Washington DC: American College of Obstetricians and Gynecologists; 1997.
ACOG Committee Opinion, Committee on Gynecologic Practice, No. 224, October 1999. Tamoxifen and the Prevention of Breast Cancer in High-Risk Women. Washington DC: American College of Obstetricians and Gynecologists; 1999.
ACOG Practice Bulletin, No. 42, April 2003. Breast Cancer Screening. Washington DC: American College of Obstetricians and Gynecologists; 2003.
American College of Radiology (ACR). Illustrated Breast Imaging Reporting and Data System (BI-RADSTM), 3rd ed. Reston, VA: American College of Radiology; 1998.
Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 2001;98:498–508.
Fisher B, Jeong J-H, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. [NSABP B-04] N Engl J Med 2002;347:567–75.
Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel project B-14 randomized trial. J Natl Cancer Inst 2001;93:684–90.
Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001;28:400–18.
Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90:1371–88.
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–50.
Grimes DA, Lobo RA. Perspectives on the Women’s Health Initiative trial of hormone replacement therapy. Obstet Gynecol 2002;100:1344–53.
Hindle WH, ed. Breast Disease for Gynecologists. Norwalk, CT: Appleton & Lange; 1990.
Hindle WH, ed. Breast Care. New York: Springer-Verlag; 1999.
Hindle WH. Breast cancer: introduction. Clin Obstet Gynecol 2002;45(3):738–45.
Hindle WH. Breast cancer: prevention and surveillance. Clin Obstet Gynecol 2002;45(3):778–83.
Hindle WH. Breast in situ carcinoma-diagnosis and treatment. Clin Obstet Gynecol 2002;45(3):774–77.
Hindle WH. Breast mass evaluation. Clin Obstet Gynecol 2002;45(3):750–57.
Hindle WH. Mammography-screening and diagnosis. Clin Obstet Gynecol 2002;45(3):746–49.
Hindle WH. Treatment of invasive carcinoma. Clin Obstet Gynecol 2002;45(3):767–69.
Hindle WH, Arias RD, Florentine B, Whang J. Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol 2000;182:1300–05.
Hindle WH, Arias RD, Felix J, Sueda A. Adaptation of FNA to office practice. Clin Obstet Gynecol 2002;45(3):761–66.
Margolese R, Poisson R, Shibata H, et al. The technique of segmental mastectomy (lumpectomy) and axillary dissection: a syllabus from the National Surgical Adjuvant Breast Project workshops. Surgery 1987;102:828–34.
Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002;52:256–76.
Morrow M, Strom EA, Bassett LW, et al. Standard for breast conserving therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002;52:277–300.
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: a systematic review. Am J Obstet Gynecol 2002;186:325–34.
Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin N Am 2000;38:625–51.
Weiss LK, Burkman RT, Cushing KL, et al. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol 2002;100:1148–58.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hindle, W.H. (2007). Breast Disease. In: Primary Care in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-32328-2_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-32328-2_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-32327-5
Online ISBN: 978-0-387-32328-2
eBook Packages: MedicineMedicine (R0)